A patient with frequent tension headaches asks the nurse about over-the-counter remedies. The nurse knows that Excedrin combines which of the following active ingredients to address pain, inflammation, and increased vascular tone associated with headaches?

Choice A reason: "I am not ready to eat lunch yet." is not a concerning statement for the patient who has completed their Albuterol nebulizer treatment. Albuterol is a medication that relaxes the muscles in the airways and increases the airflow to the lungs, which can improve the breathing and reduce the wheezing in patients with asthma¹. Albuterol does not affect the appetite or the digestion directly, but it may cause some side effects such as nausea, vomiting, or dry mouth, which may reduce the desire to eat. The nurse should respect the patient's preference and offer them food later when they are ready.

Choice B reason: "It feels like my heart is racing." is a concerning statement for the patient who has completed their Albuterol nebulizer treatment. Albuterol is a medication that relaxes the muscles in the airways and increases the airflow to the lungs, but it also stimulates the beta receptors in the heart, which can increase the heart rate and the blood pressure¹. This can cause side effects such as palpitations, chest pain, or arrhythmias, especially in patients with underlying heart conditions or those who take other medications that affect the heart. The nurse should monitor the patient's vital signs, report the finding to the prescriber, and prepare to administer interventions such as betablockers or calcium channel blockers to lower the heart rate and prevent complications.

Choice C reason: "It is easier to breathe now." is not a concerning statement for the patient who has completed their Albuterol nebulizer treatment. Albuterol is a medication that relaxes the muscles in the airways and increases the airflow to the lungs, which can improve the breathing and reduce the wheezing in patients with asthma¹. This is the expected and desired outcome of the Albuterol nebulizer treatment, which indicates that the medication is effective and the patient is responding well. The nurse should document the patient's response and continue to assess the patient's respiratory status and oxygen saturation.

Choice D reason: "I can breathe better now." is not a concerning statement for the patient who has completed their Albuterol nebulizer treatment. Albuterol is a medication that relaxes the muscles in the airways and increases the airflow to the lungs, which can improve the breathing and reduce the wheezing in patients with asthma¹. This is the expected and desired outcome of the Albuterol nebulizer treatment, which indicates that the medication is effective and the patient is responding well. The nurse should document the patient's response and continue to assess the patient's respiratory status and oxygen saturation.

Choice A reason: This is incorrect. SQ (subcutaneous) administration involves injecting a drug into the fatty tissue under the skin. This route is slower than IV or IM administration, as the drug has to diffuse through the tissue before reaching the bloodstream.

Choice B reason: This is incorrect. PO (by mouth) administration involves swallowing a drug and absorbing it through the digestive system. This route is the slowest of all, as the drug has to pass through the stomach and the liver before reaching the bloodstream. The drug may also be affected by the first pass effect, which reduces its bioavailability.

Choice C reason: This is correct. IV (intravenous) administration involves injecting a drug directly into a vein. This route is the fastest of all, as the drug enters the bloodstream immediately and reaches the target site quickly. The drug also has 100% bioavailability, meaning none of it is lost or degraded.

Choice D reason: This is incorrect. IM (intramuscular) administration involves injecting a drug into a muscle. This route is faster than SQ or PO administration, as the drug can be absorbed by the capillaries in the muscle. However, it is still slower than IV administration, as the drug has to cross the muscle membrane before reaching the bloodstream.